INCOME RESEARCH & MANAGEMENT - Q4 2019 holdings

$249 Million is the total value of INCOME RESEARCH & MANAGEMENT's 21 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 10.0% .

 Value Shares↓ Weighting
SellPRICELINE GRP INCnote 0.900% 9/1$22,112,000
-3.9%
19,188,000
-4.8%
8.87%
-20.5%
SellARES CAP CORPnote 3.750% 2/0$22,011,000
+0.1%
21,235,000
-0.8%
8.83%
-17.3%
SellSPIRIT RLTY CAP INC NEWnote 3.750% 5/1$20,456,000
+2.3%
19,688,000
-0.7%
8.21%
-15.4%
SellTEVA PHARMACEUTICAL FIN LLCdbcv 0.250% 2/0$14,732,000
+5.2%
15,541,000
-0.3%
5.91%
-13.0%
SellANTHEM INCnote 2.750%10/1$10,936,000
-42.4%
2,604,000
-46.3%
4.39%
-52.4%
SellALZA CORPsdcv 7/2$7,748,000
-44.7%
3,864,000
-47.3%
3.11%
-54.3%
SellON SEMICONDUCTOR CORPnote 1.000%12/0$1,025,000
+2.5%
754,000
-7.4%
0.41%
-15.3%
SellNABORS INDS INC NEWnote 0.750% 1/1$943,000
-5.7%
1,265,000
-8.0%
0.38%
-22.1%
SellDANAHER CORPORATIONdbcv 1/2$667,000
-33.3%
114,000
-56.8%
0.27%
-44.7%
ExitNOVELLUS SYS INCnote 2.625% 5/1$0-2,498,000
-100.0%
-6.80%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-01-29
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
BK OF AMERICA CORP36Q2 20232.1%
WELLS FARGO CO NEW35Q2 20234.0%
ALZA CORP21Q2 20183.9%
FIDELITY NATIONAL FINANCIAL21Q2 20183.8%
TEVA PHARMACEUTICAL FIN LLC21Q2 20185.3%
DANAHER CORP DEL21Q2 20183.8%
JEFFERIES GROUP INC NEW19Q4 20175.5%
OLD REP INTL CORP19Q4 20174.8%
RPM INTL INC19Q2 20184.3%
NOVELLUS SYS INC19Q2 20184.5%

View INCOME RESEARCH & MANAGEMENT's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-04-25
13F-HR2024-01-19
13F-HR2023-10-24
13F-HR2023-07-21
13F-HR2023-04-20
13F-HR2023-01-31
13F-HR2022-10-20
13F-HR2022-07-21
13F-HR/A2022-04-22
13F-HR2022-04-20

View INCOME RESEARCH & MANAGEMENT's complete filings history.

Compare quarters

Export INCOME RESEARCH & MANAGEMENT's holdings